Figure 1. Utilization of implantable cardioverter defibrillator for primary prevention of sudden cardiac arrest. ICD: Implantable Cardioverter Defibrillator.
| Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc |
| Journal website https://www.cardiologyres.org |
Original Article
Volume 2, Number 1, February 2011, pages 1-6
Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest
Figures
Table
| Total (275) | No ICD | Yes ICD | P value | |
|---|---|---|---|---|
| ICD: Implantable Cardioverter Defibrillator | ||||
| LVEF: Left Ventricular Ejection Fraction | ||||
| ACE-I: Angiotensin Converting Enzyme Inhibitor | ||||
| ARB: Angiotensin Receptor Blocker | ||||
| Age (mean ± SD) in yr | 73.4 ± 13.1 | 73.12 ± 14.0 | 73.86 ± 11.9 | 0.64 |
| Gender (women) | 101 (37%) | 66 (65) | 35 (35) | 0.02 |
| Race (Caucasian) | 236 (86%) | 132 (56) | 104 (44) | 0.5 |
| LVEF | 24.09 ± 6.72 | 23.7 ± 7.05 | 24.5 ± 6.2 | 0.35 |
| LVEF ≤ 30% | 243 (88%) | 138 (57) | 105 (43) | 0.95 |
| Cardiomyopathy | ||||
| Ischemic | 228 (83%) | 127 (56) | 101 (44) | 0.44 |
| Non-Ischemic | 47 (17%) | 29 (62) | 18 (38) | |
| ACE-I/ARB | 233 (86%) | 128 (55) | 105 (45) | 0.25 |
| Statin | 202 (75%) | 113 (56) | 89 (44) | 0.98 |
| Aspirin | 200 (76%) | 114 (57) | 86 (43) | 0.74 |
| Beta blocker | 255 (94%) | 145 (57) | 110 (43) | 0.29 |
| Serum BUN (in mgs%) | 27.61 ± 14.25 | 27.4 ± 15.6 | 27.8 ± 12.2 | 0.79 |
| Serum Creatinine (in mgs%) | 1.35 ± 0.96 | 1.41 ± 1.21 | 1.26 ± 0.43 | 0.19 |